MACS1 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of MACS1, which stands for Mast Cell Serine Protease 1. This protein, predominantly expressed in mast cells, plays a significant role in processes related to immune regulation, including the breakdown of extracellular matrix components and the regulation of inflammatory responses. As a serine protease, MACS1 is involved in cleaving peptide bonds in proteins, influencing various cellular and molecular functions, such as tissue remodeling, immune cell migration, and the modulation of signaling pathways within the immune system. By inhibiting MACS1, researchers aim to disrupt these proteolytic processes, enabling a deeper understanding of its role in the regulation of immune responses, tissue repair, and protein degradation.
In research, MACS1 inhibitors are critical tools for exploring the molecular mechanisms by which MACS1 contributes to immune system regulation and extracellular matrix dynamics. Blocking MACS1 activity allows scientists to investigate how its inhibition affects downstream biological processes, such as the breakdown of extracellular proteins, immune cell signaling, and the regulation of mast cell-mediated responses. This inhibition also enables the study of how MACS1 influences interactions between mast cells and other immune cells, shedding light on its role in orchestrating complex immune pathways. Furthermore, MACS1 inhibitors help researchers understand the broader implications of protease activity in processes such as inflammation, cellular migration, and tissue repair. Through these studies, the use of MACS1 inhibitors provides insights into the role of serine proteases in immune regulation and the intricate molecular networks that maintain immune balance and tissue integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Directly binds to SMO, inhibiting Shh pathway. Theoretically, if Shh expression is downregulated, Macs1's enhancer activity could be reduced due to decreased need for its regulated gene expression. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $80.00 $96.00 | 1 | |
Specifically inhibits SMO. Reduced Shh signaling may reduce the drive for Macs1-mediated Shh gene expression, possibly diminishing Macs1's enhancer function. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
Antagonizes SMO. A dampened Shh pathway might indirectly lower the utilization or importance of Macs1's enhancer activity for Shh expression. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $63.00 $128.00 $200.00 | 6 | |
Inhibits GLI1 & GLI2. This could reduce the overall activity of the Shh pathway, potentially diminishing the regulatory role of Macs1 in Shh expression. | ||||||
BMS 833923 | 1059734-66-5 | sc-503864 | 10 mg | $240.00 | ||
Inhibits SMO. As with other SMO inhibitors, this could theoretically reduce the need for Macs1-mediated regulation of Shh expression. | ||||||
HPI-4 | 302803-72-1 | sc-358720 sc-358720A | 5 mg 25 mg | $133.00 $530.00 | ||
Targets GLI1 & GLI2. The reduction in GLI activity could diminish the role of Macs1 in Shh expression. | ||||||
RU-SKI 43 | 1043797-53-0 | sc-507508 | 5 mg | $395.00 | ||
Inhibits HHAT. By affecting Shh palmitoylation and activity, there could be an indirect reduction in the necessity for Macs1's regulatory function on Shh. | ||||||
CUR 61414 | 334998-36-6 | sc-211143 | 1 mg | $380.00 | 1 | |
Antagonizes SMO. This could theoretically reduce the drive or need for Macs1's enhancer activity in Shh gene expression. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
Inhibits SMO. Beyond its antifungal role, its Shh inhibition might lower the demand for Macs1's regulatory influence on Shh. | ||||||